Skip to main content
Home

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Covid-19 vaccine injected through skin.
Covid-19 vaccine injected through skin. - Credit: Leids Universitair Medisch Centrum (LUMC) / Leids Universitair Medisch Centrum (LUMC) - License: All Rights Reserved
Health
Moderna
covid-19 vaccine
LUMC
Wednesday, 16 June 2021 - 17:20
Share this:
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • reddit

Moderna Covid vaccine can be safely injected into skin tissue: LUMC

The Moderna Covid-19 vaccine can be injected through skin just as safely as through muscle, the initial research of Leiden University Medical Center (LUMC) proved. The advantage of this vaccination technique is that it requires a significantly smaller dose of the vaccine.

”In stage 1 of our study, we saw that administration of a tenth of the dose into the skin is safe, and that even with this low dose, antibodies were generated in all participants, comparable to the level of someone who previously had COVID-19,” said Geert Roozen, a physician and researcher of infectious diseases.

Administering the vaccine into the skin is not a new technique but it was not known whether the method can also be used with the new Covid-19 vaccines. The second stage of LUMC research, that has recently been completed established that an even smaller dose, one fifth the dose needed for muscle injection, can provide adequate protection against Covid-19.

“Because all participants from stage 1 produced significant amounts of antibodies, it is expected that this will be the case at a fifth of the dose. So we are very hopeful, but we will wait a little longer to hang out the flag until we have all the data about the antibodies in view," said the lead researcher Anna Roukens.

Other scientists will also have to assess the research before it is officially published. Moving forward, the researchers are currently also recruiting participants for stage 3 of the study.

“Just like in stage 2, we look here to see whether a fifth of the normal dose generates as many antibodies as the muscle dose, but then in a larger group of participants. Because the vaccination campaign in the Netherlands is going so well, it is a challenge to find people who have not been vaccinated,” said Roozen.

The study, which is conducted in collaboration with the Center for Human Drug Research (CHDR), is expected to be completed after the summer. Those interested in participating in stage 3 of the study can register using the study's website.

”There is still a shortage of vaccinations in large parts of the world. Five times more people can be vaccinated with the same amount of vaccine. And that's why we are doing this,” said Roukens.

Follow us:

Latest stories

  • Ban football hooligans from next away match if they misbehave: Police Chief
  • Amsterdam court to hear case against xHamster for showing porn without consent
  • Netherlands lands NATO Innovation Fund headquarters
  • Patients find it harder to get an appointment with their doctor
  • Suspects in hate speech laser projections face community service for Breda attack
  • Romania detains 3 Dutch people for phishing scams; Fourth held in Enschede

Top stories

  • Ban football hooligans from next away match if they misbehave: Police Chief
  • Netherlands lands NATO Innovation Fund headquarters
  • IPCC: global warming "likely" to pass 1.5 degree mark, but there are bright spots
  • Russia’s Medvedev suggests possible rocket attack on ICC in The Hague
  • The Netherlands remains in 5th on World Happiness Report
  • Share of social housing rentals keeps falling despite gov't plans

© 2012-2023, NL Times, All rights reserved.

Footer menu

  • Privacy
  • Contact
  • Partner content